| AASLD

In the first part of the webinar, we will provide an overview regarding the definitions of acute-on-chronic liver failure and the management of the cirrhotic patient with multi-organ system failure.

Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low‐Density Lipoprotein Cholesterol

Read more about Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low‐Density Lipoprotein Cholesterol

Christian Labenz, Jürgen H. Prochaska, Yvonne Huber, Michael Nagel, Beate K. Straub, Philipp Wild, Peter R. Galle, Jörn M. Schattenberg – 30 September 2019 – Cardiovascular disease (CVD) is the leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD). The current analysis expands the knowledge on atherogenic lipid profiles in NAFLD by modeling changes in low‐density lipoprotein cholesterol (LDL‐C) and total cholesterol (TC) in a prospectively enrolling real‐life study cohort to inform physicians on the cardiovascular (CV) event risk based on these changes.